trial · primary record
ASP388B
Locally Advanced or Metastatic Solid Tumors
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 392 |
| Primary completion | 2030-05-31 |
| Primary endpoint | Number of Participants with Dose Limiting Toxicities (DLTs) |
| Registry ID | NCT07730021 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:08.532Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07730021
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.